Top Anti Cancer Imported Medicine Drugs in India - Pharma Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Farydak (Panobinostat) Medicine in India

Farydak (Panobinostat)

Medicine name : Farydak

Generic name : Panobinostat

Manufactured By : Secura

Indications : Multiple Myeloma

Medicine Description : Farydak is a histone deacetylase (HDAC) inhibitor used for multiple myeloma in combination with other therapies. It disrupts cancer cell DNA activity, slowing tumor growth. Given orally, it enhances treatment efficacy. Side effects include severe diarrhea, fatigue, nausea, and low blood counts. Close cardiac and gastrointestinal monitoring is needed to manage toxicity.

Product Introduction

Farydak (Panobinostat) is an anticancer medicine used in combination with other treatments for adults with multiple myeloma whose disease has returned or has not responded adequately to previous therapies. It belongs to a group of medicines called histone deacetylase (HDAC) inhibitors and works by affecting proteins involved in cancer cell growth and survival, helping to slow the progression of multiple myeloma.

Farydak (Panobinostat) should be taken exactly as prescribed by your doctor. It is usually taken on specific days of a treatment cycle and may be taken with or without food. Swallow it whole with water and do not crush, chew, or open it. The dose and treatment schedule are determined by your doctor based on your condition and response to treatment. Regular blood tests and medical monitoring may be required during treatment.

Common side effects of Farydak (Panobinostat) may include diarrhea, fatigue, nausea, vomiting, decreased appetite, low blood cell counts, fever, swelling, and headache. Serious side effects such as severe diarrhea, bleeding, infections, liver problems, or heart rhythm changes may also occur. Inform your doctor if any side effect becomes severe or persistent. Tell your doctor about your medical history and all medicines, vitamins, herbal products, or dietary supplements you are taking before starting treatment.

Uses Of Farydak (Panobinostat)

Treatment of Multiple Myeloma

Benefits Of Farydak

Farydak (Panobinostat) is used in combination with other medicines to treat multiple myeloma in adults whose cancer has returned or has not responded adequately to previous treatments. It blocks enzymes called histone deacetylases (HDACs), which can interfere with the growth and survival of abnormal myeloma cells. This helps reduce cancer cell growth and may slow the progression of multiple myeloma.

Side Effects Of Farydak (Panobinostat)

Some side effects of Farydak (Panobinostat) may improve as your body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Farydak (Panobinostat)

  • Diarrhea
  • Fatigue
  • Nausea
  • Vomiting
  • Decreased appetite
  • Low platelet count
  • Low white blood cell count
  • Fever
  • Swelling
  • Headache
How To Use Farydak

Farydak (Panobinostat) should be taken exactly as prescribed by your doctor, usually in combination with other medicines for multiple myeloma. It is taken on specific days according to your treatment cycle and may be taken with or without food. Swallow the medicine whole with water and do not crush, chew, or open it. Do not change the dose or treatment schedule without consulting your doctor. Regular blood tests and medical check-ups may be required during treatment.

How Farydak (Panobinostat) Works

Farydak (Panobinostat) works by blocking enzymes called histone deacetylases (HDACs). These enzymes help regulate proteins involved in cancer cell growth and survival. By inhibiting HDAC activity, Panobinostat causes changes in cancer cells that can slow their growth and eventually lead to their death. This helps reduce abnormal myeloma cells and may slow the progression of multiple myeloma.

Storage Conditions
  • Maintain the medicine at room temperature below 30°C.
  • Keep it in a dry area, protected from heat and direct sunlight.
  • Leave the product in its original packaging until it is needed.
  • Store it in a secure place that is inaccessible to children.
Safety Advice

AlcoholAlcohol CONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Farydak (Panobinostat).

PregnancyPregnancy CONSULT YOUR DOCTOR

Farydak (Panobinostat) may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant.

BreastfeedingBreastfeeding CONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment with Farydak (Panobinostat). Consult your doctor for guidance.

DrivingDriving CONSULT YOUR DOCTOR

Farydak (Panobinostat) may cause dizziness, fatigue, or weakness. Avoid driving if these symptoms affect your alertness.

KidneyKidney CAUTION

Inform your doctor if you have kidney problems before starting Farydak (Panobinostat). Your doctor will determine the appropriate monitoring.

LiverLiver CAUTION

Farydak (Panobinostat) may affect liver function. Inform your doctor about any liver disease, as liver function may be monitored during treatment.

Quick Tips
  • Take Farydak (Panobinostat) exactly as prescribed and follow the specific treatment schedule given by your doctor.
  • Attend regular blood tests and medical check-ups to monitor your blood counts, liver function, and overall response to treatment.
  • Inform your doctor promptly if you develop fever, unusual bleeding, severe weakness, or signs of infection.
  • Inform your doctor about all medicines, vitamins, herbal products, and dietary supplements you are taking to help prevent possible drug interactions.
  • Do not change, interrupt, or stop Farydak (Panobinostat) treatment without your doctor's advice.
  • Read More About - Farydak (Panobinostat) from Pharma Five.
About Pharma Five

Pharma Five, may assist patients in arranging the import of Farydak (Panobinostat) in small quantities for personal use. To facilitate the process, the applicant is required to submit an application in Form 12A together with a prescription issued by a Registered Medical Practitioner (RMP).

Pharma Five provides experienced consultancy and facilitation services to help patients access Farydak (Panobinostat) and other specialized medicines through appropriate import-related assistance. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

References
  1. https://go.drugbank.com/drugs/DB06603
  2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf
  3. https://www.ema.europa.eu/en/medicines/human/EPAR/farydak
Faq

General Question

Farydak (Panobinostat) is a prescription medicine used to treat multiple myeloma in combination with other drugs in patients who have received at least two prior therapies, including bortezomib and an immunomodulatory agent.

Farydak is a histone deacetylase (HDAC) inhibitor. It works by interfering with enzymes that cancer cells need to grow and divide, leading to cancer cell death.

Farydak is prescribed for adults with relapsed or refractory multiple myeloma who have already been treated with at least two prior therapies.

Farydak is taken orally in capsule form, typically three times a week (such as Monday, Wednesday, and Friday) on specific weeks of a 21-day treatment cycle, as directed by your doctor.

Common side effects include diarrhea, fatigue, nausea, vomiting, loss of appetite, and low blood cell counts.

Yes, Farydak can cause serious side effects such as severe diarrhea, heart rhythm problems (QT prolongation), infections, and bleeding. Contact your doctor if you experience dizziness, rapid heartbeat, or unusual bleeding.

Farydak is taken as long as it remains effective and tolerable. Your doctor will determine the appropriate treatment duration based on your condition.

Avoid alcohol while taking Farydak, as it can increase the risk of liver damage and worsen side effects like dizziness or fatigue.

No, Farydak may harm an unborn baby. Both men and women should use effective contraception during treatment and for a period after the last dose.

Yes, Farydak may interact with many medications, including those affecting liver enzymes and heart rhythm. Inform your doctor of all medicines, including supplements and herbal products.

If you miss a dose, take it as soon as you remember on the same day. If you miss the whole day, skip the dose and resume the schedule the next planned day. Do not take extra capsules to make up for a missed dose.

Yes, Farydak can be taken with or without food, but it should be taken at the same time on scheduled days.

Get regular blood tests, stay hydrated, report severe diarrhea immediately, and avoid people with infections as your immune system may be weakened.

Store Farydak at room temperature, away from moisture and heat, and keep it out of reach of children.

Farydak is available at specialty pharmacies with a prescription. Your doctor or treatment center can guide you to an appropriate pharmacy or provider. Pharma Five assists in its procurement.

Timely Service
Doorstep Delivery
Hassle-Free Process
100% Genuine Sources